DXT TOR Week ended 31 Jul 2026

Weekly Investor Report

Dexterra Group Inc. · Industrials · Specialty Business Services

Open interactive chart View report data
Latest close 15.58 CAD
-3.1% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 19.9% above the Trend Line and sits at 93.2% of its 52-week range. The latest completed week returned -3.1%, after a 12.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 52/100. Near-term considerations: price is close to its 52-week high.

Setup score 79 out of 100
Latest Close 15.58 CAD 31 Jul 2026
1W Return -3.1% latest completed week
4W Return 12.2% short-term follow-through
12W Return 25.0% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • The trend backdrop is active with a 102-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 5 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.1% Latest completed week; four-week move 12.2%. Indicator stack 100/95 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 52/100 12 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 19.9% above the Trend Line and sits at 93.2% of its 52-week range. The latest completed week returned -3.1%, after a 12.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9412-week average 0.72

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.94Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers

No recent accumulation markers. 5 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 12.2% over four weeks, 25.0% over 12 weeks, and 67.8% over one year. The current trend has remained active for 102 consecutive weeks.

Performance by holding period

1W-3.1%
4W12.2%
12W25.0%
26W21.5%
52W67.8%
Active trend streak102 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.42Latest activity-pressure read.
Pressure change243.4%Four-week change in activity pressure.
Leadership20.60Latest relative-leadership reading.
RS change117.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength59/100Blend of value, momentum, and quality. Underlying universe rank 42; rank 1 is best.
Value34/100Relative valuation strength. Underlying universe rank 67; rank 1 is best.
Quality68/100Profitability and accounting quality. Underlying universe rank 33; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth77/100Revenue and earnings growth. Underlying universe rank 24; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework53/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
24.8x
Price divided by trailing earnings.
Price / sales
1.0x
Market value relative to trailing revenue.
EV / EBITDA
11.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
17.9%
Gross profit retained from each unit of revenue.
Operating margin
6.2%
Operating profit retained from revenue.
Free-cash-flow margin
7.1%
Free cash flow generated from revenue.
Return on invested capital
9.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
3.8%
Latest one-year revenue growth.
EPS growth
106.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
82.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.5%
Cash dividends relative to market value.
Buyback yield
1.1%
Net share repurchases relative to market value.
Shareholder yield
3.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 12 relevant articles.

2 positive · 9 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.1%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+10.1%Week of 17 Jul.
Worst week-7.5%Week of 13 Mar.
Latest week-3.1%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains12
Flat weeks0
Modest losses10
Sharp losses1
Recent vol3.7%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split29/22Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape78/100

Trend, activity pressure, participation, and risk combine to a 78/100 tape read.

 Indicator analysis79/100

Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 12/12.

Activity pressure 0.94; 5 reversal markers Factors60/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 24; Small Cap Core rank 43 SVQF53/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 141.5 of 298 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 12 relevant articles.

Dexterra Group, Inc. Revenue Breakdown – TSX:DXT Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202615.58 CAD-3.1%13.00 CAD8.12 CAD1.4220.60274.0KOn
24 Jul 202616.08 CAD3.8%12.86 CAD8.05 CAD1.2624.61392.6KOn
17 Jul 202615.49 CAD10.1%12.72 CAD7.98 CAD1.0021.08411.9KOn
10 Jul 202614.07 CAD1.4%12.60 CAD7.91 CAD0.6310.4584.2KOn
3 Jul 202613.88 CAD1.7%12.53 CAD7.86 CAD0.419.4986.6KOn
26 Jun 202613.65 CAD6.8%12.46 CAD7.80 CAD0.158.8513.3KOn
19 Jun 202612.79 CAD-1.8%12.40 CAD7.74 CAD0.012.327.1KOn
12 Jun 202613.01 CAD2.2%12.34 CAD7.69 CAD0.034.4710.8KOn
5 Jun 202612.74 CAD-2.4%12.27 CAD7.64 CAD0.094.0911.7KOn
29 May 202613.05 CAD-1.8%12.19 CAD7.59 CAD0.015.85144.9KOn
22 May 202613.29 CAD3.2%12.10 CAD7.54 CAD-0.269.09130.2KOn
15 May 202612.89 CAD3.3%12.00 CAD7.48 CAD-0.638.13647.2KOn
8 May 202612.47 CAD4.4%11.90 CAD7.43 CAD-0.994.22180.3KOn
1 May 202611.94 CAD1.8%11.82 CAD7.38 CAD-1.080.58175.8KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.